TRAIL-R Atrimer (Anaphore)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTRAIL-R Atrimer (Anaphore)
Drug Alias NameDeath receptor agonist Atrimers (Anaphore)Atrimer (Anaphore)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10A agonistsTumor necrosis factor receptor superfamily member 10B agonists
TargetsTumor necrosis factor receptor superfamily member 10BTumor necrosis factor receptor superfamily member 10A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBird Rock Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBird Rock Bio Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A